Vontier Corporation
VNT · Healthcare · $4.4B mkt cap · FY2025 filings · Narrow moat ·
Wonderful & reasonably priced
The five investor questions
2021–2025 (latest 5 aligned FYs; v3 window cap 5): revenue $3.0B to $3.1B, increasing; diluted EPS 2.43 to 2.76, increasing.
Median gross margin 43.9% over 5y, very stable.
Median ROIC 16.7%, above the 12% hurdle in 100% of years.
Net debt/EBITDA 2.6x, no material interest expense disclosed.
Owner earnings -0.8%/yr.
Price vs. conservative owner-earnings floor
A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.
- Owner earnings (normalized)
- $406M
- Owner-earnings floor / share
- $31.73
- Capped-growth comparison / share
- $44.65
- Recent price
- $30.78
- Price vs. owner-earnings floor
- 3% below owner-earnings floor
A discount this large is often a warning rather than a bargain — the market may expect earnings to keep falling. See the revenue trend above.
How to read this
What today’s price assumes: owner earnings shrinking ~1%/yr over 5 years. The floor assumes owner earnings stay flat (0% growth).
We solve for the constant annual change in owner earnings that would make the five-year floor equal today’s price. This keeps the existing model inputs and calculation unchanged; it is an expectations lens, not a forecast.
This floor assumes trailing owner earnings persist — unreliable for declining businesses. The recent FY revenue series does not trigger the three-consecutive-declines flag.
Among the current top-score group, the median current price is 239% above the floor across 48 of the current top 50 companies by Moat Score with both values.
Score records captured Jul 26, 2026.
Exactly which 50 companies?
FTNT, META, MEDP, IBEX, MSFT, GOOGL, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, VEEV, GRMN, SSD, MNST, DOCS, MCO, CPRT, NTAP, LRCX, NVDA, CORT, SFM, MPTI, ULTA, SN, RMD, ROL, PAYC, IRMD, INTU, DECK, MORN, LGCY, DAL, GWW, ISRG, MPWR, CTAS, LOPE, MRK, CMG, FAST, BKNG, ORLY
Missing a usable price or floor: ANF, BKNG.
Model details under moat-index@3.0.0: zero-growth floor 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 3% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.
9 years of fundamentals
The business, in plain English
Across the filed record, revenue grew from $2.7B (FY2018) to $3.1B (FY2025) — about 2.1% a year compounded over 7 years.
It earned 15.8% on invested capital in the latest filed year, FY2025. Across the full 8-year measurable filed record, median ROIC was 16.7%. Over the v3 recent window (8 measurable filed years), median ROIC was 16.7%. The Returns on Capital filter above scores it 86/100.
The balance sheet carried $2.1B of total debt in FY2025 against $406M of owner earnings — roughly 5.2 years of owner earnings to retire it all. Balance-Sheet Safety scores it 64/100.
Put together: Returns on Capital is the strongest of the five filters (86/100) and Capital Discipline the weakest (55/100), which is how VNT lands at 70/100 — a Narrow moat.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in VNT’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Breaks in the line mark methodology or normalizer upgrades — readings across versions aren’t compared, so a level shift there isn’t a change in the business.
Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars
- Normalizer upgraded unstamped (version unknown)tomoat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
- Methodology upgraded moat-index@2.0.0tomoat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
- Methodology upgraded moat-index@1.2.0tomoat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026
Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.
Track record
How Vontier Corporation’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.
How to read this: each dot is what the engine would have scored VNT on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.
Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.
What followed, in the years it rated Wide
In the reconstructed history shown, VNT did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.
Healthcare context
#58 of 728 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #56INDV Indivior Pharmaceuticals, Inc.70.0 out of 100, Narrow moatNarrow moat
- #57EMBC EMBECTA CORP.70.0 out of 100, Narrow moatNarrow moat
- #59CHE CHEMED CORPORATION69.3 out of 100, Narrow moatNarrow moat
- #60ONTO ONTO INNOVATION INC.69.2 out of 100, Narrow moatNarrow moat
Compare VNT with its nearest peers →All Healthcare companies on the Index →
Common questions about VNT
- Does Vontier Corporation have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores Vontier Corporation (VNT) 69.5 out of 100 — a Narrow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 68, pricing power 75, returns on capital 86, balance-sheet safety 64, capital discipline 55.
- Is VNT trading below the conservative owner-earnings estimate?
- The conservative owner-earnings floor is $31.73 per share. It capitalizes normalized owner earnings at a 9% rate and assumes 0% growth. Versus a recent price of $30.78, that is 3% below owner-earnings floor. The model also publishes a capped-growth comparison, but the floor is the cautious baseline. It assumes trailing owner earnings persist and is unreliable for declining businesses. This is an educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.
- How has VNT's Moat Score changed over time?
- The record logs 16 readings since Jul 17, 2026; the latest reads 69.5 out of 100 (narrow moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.